Search

Search Constraints

You searched for: Author/Creator Ehrenberg, Alexander J.

Search Results

1. [P1–010]: INVESTIGATING THE SELECTIVE VULNERABILITY OF ALZHEIMER's DISEASE IN FIVE SUBCORTICAL NUCLEI AS COMPARED TO FOUR REPEAT TAUOPATHIES. (1st July 2017)

2. [P1–466]: INVESTIGATING THE SELECTIVE VULNERABILITY OF ALZHEIMER's DISEASE IN FIVE SUBCORTICAL NUCLEI AS COMPARED TO FOUR REPEAT TAUOPATHIES. (1st July 2017)

3. [P2–178]: NEURONAL POPULATION AND NUCLEAR VOLUME CHANGES IN THE DORSAL RAPHE NUCLEUS IN AGE AND AD: A POST‐MORTEM STEREOLOGICAL INVESTIGATION. (1st July 2017)

4. [P3–449]: THE CONTRIBUTION OF HYPERPHOSPHORYLATED‐TAU PATHOLOGY TO NEUROPSYCHIATRIC SYMPTOMS IN ALZHEIMER's DISEASE. (1st July 2017)

5. [P4–273]: TAU BURDEN IN OREXINERGIC WAKE‐PROMOTING NEURONS IN ALZHEIMER'S DISEASE IN COMPARISON TO CORTICAL BASAL DEGENERATION AND PROGRESSIVE SUPRANUCLEAR PALSY: A NEUROPATHOLOGICAL IMPLICATION IN SLEEP DISTURBANCES. (1st July 2017)

6. A novel temporal‐predominant neuro‐astroglial tauopathy associated with TMEM106B gene polymorphism in FTLD/ALS‐TDP. (11th February 2021)

7. Caspase‐6‐cleaved tau is relevant in Alzheimer's disease and marginal in four‐repeat tauopathies: Diagnostic and therapeutic implications. (2nd June 2022)

8. Caspase‐6‐cleaved tau is relevant in Alzheimer's disease but not in 4‐repeat tauopathies: Diagnostic and therapeutic implications. (1st February 2022)

9. Caspase‐6‐cleaved tau is relevant in Alzheimer's disease but not in 4‐repeat tauopathies: Diagnostic and therapeutic implications. (December 2021)